The Cannabis Paradox: How Australia's Medical Market Boom Became a Domestic Industry Crisis

The industry's 38 tonnes of unsold inventory isn't just an economic problem. It's karma.

Cann Group Secures Major Debt Restructure and $9M Capital Raise

The debt forgiveness of $54.7 million represents an 81% reduction in the company's debt and will increase Cann Group's net assets by approximately $60 million.

From Prohibition to Home Grows: Lessons from Germany's Cannabis Act for Australia's Medical Cannabis Crisis

The contrast between Germany's success and Australia's stagnation raises a fundamental question: what structural differences enable one country to achieve rapid market transformation while another remains locked in gatekeeping and corporate control?

The High Cost of Relief: How Medical Cannabis Pricing Leaves Patients Behind

As health bodies call for crackdown on rogue operators, affordability crisis goes unaddressed.

A Guide for Medicinal Cannabis Users on Completing the TGA Unapproved Product Survey

The Reviewing the Safety and Regulatory Oversight of Unapproved Medicinal Cannabis Products consultation commenced on 11 August 2025 and will close on 7 October.

Ecofibre Limited (ASX: EOF) delisted from the ASX

Ecofibre Limited was an Australian biotechnology company focused on hemp-derived products and technologies. The company listed on the ASX on March 29, 2019, through an IPO that raised $20 million at $1 per share, giving it a market capitalization of $309 million on listing¹. The business was headed by rich-lister

The Home Cultivation Gap: Comparing Medical Cannabis Access Rights in Australia and Canada

The prohibition creates a two-tiered system where access depends on wealth. Canadian patients can grow unlimited plants based on prescription. Low-income patients aren't excluded due to cost barriers.

TGA's Medical Cannabis 'Safety Review': Why Patients Should Be Concerned About Proposed Changes

The consultation does not address home cultivation as a potential solution to affordability concerns, despite this approach being adopted in countries like Canada and several European nations.

Fatal Fungal Contamination Highlights Critical Gap in Medical Cannabis Regulation

A groundbreaking study has provided the first definitive proof that legal medical cannabis can be a deadly source of infection for vulnerable patients.

Temperature's Impact on Cannabis: New Research Reveals Optimal Growing Conditions for Purple Strains

The research suggests that cannabis cultivators face a trade-off when growing purple varieties.

Double the Road Toll, Half the Attention: How Restrictive Cannabis Guidelines May Worsen Australia's Overdose Crisis

Australia's approach to road safety offers valuable lessons for drug policy.

Thailand’s Cannabis Flip-Flop: Legalisation’s Political Ping-Pong

This duality—strict law, informal leniency—offers a glimpse into what cannabis may become in Thailand: legal enough to use, risky enough to sensationalise.